Work

Gemcitabine kills proliferating endothelial cells exclusively via acid sphingomyelinase activation

Year: 2017

Type: article

Source: Cellular Signalling

DOI: 10.1016/j.cellsig.2017.02.021

Authors: Albert J. van Hell, Adriana Haimovitz-Friedman, Zvi Fuks, William D. Tap, Richard Kolesnick

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Sphingolipid Metabolism and Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Memorial Sloan-Kettering Cancer Center, Cycle for Survival, National Institutes of Health, National Cancer Institute

Awards: Sphingolipid-Based Anti-Angiogenic Chemosensitization, Cancer Center Support Grant

OpenAlex ID: W2591500257

FWCI: 0.776

Cites: 43

Cited by: 15

Related to: 10